Vascular Stent Market Report 2026

Vascular Stent Market Overview

• Vascular Stent market size has reached to $17.25 billion in 2025 • Expected to grow to $28.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: The Impact Of Rising Healthcare Expenditure On The Vascular Stent Market • Market Trend: Strategic Collaborations And Partnerships Driving Expansion In The Vascular Stent Market • North America was the largest region in 2025.

What Is Covered Under Vascular Stent Market?

A vascular stent refers to the small metal mesh tubular scaffolds that are used to prevent acute vessel closure and improve blood flow when a vein or artery is too narrow or blocked, resulting in late restenosis in a variety of vessels, such as coronary arteries. The procedure in which these stents are used is known as ‘vascular stenting.’ These stents are placed to widen arteries clogged with deposits and to facilitate fast recovery by reducing the risk of infection and physical trauma. The main products of a vascular stent are coronary stents, peripheral vascular stents, and EVAR stent grafts. The coronary stents are used to treat narrowed coronary arteries that provide the heart with oxygen-rich blood and prevent the artery from closing up again. The term ‘coronary stent’ in the vascular stent market refers to a stent that is a small, metal mesh tube that expands inside a coronary artery and is often placed during or immediately after angioplasty. The various types of vascular stents include bare metal stents, bio-engineered stents, bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents that are made of metallic, cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymer materials. The modes of delivery include balloon-expandable stents and self-expanding stents that are used in ambulatory surgical center, cardiac center, and hospitals.

What Is The Vascular Stent Market Growth Forecast?

The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $28.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for next-generation stent technologies, rising focus on personalized cardiovascular treatments, expansion of minimally invasive cardiac care, growing investments in advanced biomaterials, increasing adoption of digital imaging-guided interventions. Major trends in the forecast period include increasing adoption of drug-eluting and bioresorbable stents, rising demand for minimally invasive vascular procedures, growing use of advanced alloy and polymer materials, expansion of peripheral vascular interventions, enhanced focus on long-term restenosis prevention.

Global Vascular Stent Market Segmentation

1) By Product: Coronary Stents, Peripheral Vascular Stents 2) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel 3) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent 4) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital Subsegments: 1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents 2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

What Is The Driver Of The Vascular Stent Market?

The increasing healthcare expenditure is expected to propel the growth of the vascular stent market. Healthcare expenditure refers to the total amount of resources, typically measured in monetary terms, that a country, organization, or individual spends on healthcare-related goods and services within a specific period. Increasing healthcare spending allows for better infrastructure, improved healthcare facilities, and increased awareness, all of which positively impact the diagnosis and treatment of vascular diseases. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, an increasing healthcare expenditure is driving the vascular stent industry forward.

Key Players In The Global Vascular Stent Market

Major companies operating in the vascular stent market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Cook Medical, W. L. Gore & Associates, Meril Life Sciences, Sahajanand Medical Technologies, Translumina, Lepu Medical Technology, Stentys, Endologix, JOTEC, Hexacath, iVascular, Balton, Opto Circuits

Global Vascular Stent Market Trends and Insights

Major companies are strategically entering partnerships and collaborations with start-ups and mid-sized companies in the vascular stent market to broaden the products and services offered by the company. Strategic collaborations and partnership agreements help companies expand their existing product portfolio and geographical reach. For instance, in September 2023, The Electrospinning Company, a UK based manufacturer advanced biomaterials for use in implantable tissue-regenerative devices partnered with Relisys Medical Devices, an India based manufacturer of highly innovative cardiovascular medical devices, to develop innovative products which could advance cardiovascular care and revolutionize patient outcomes. With this partnership Electrospinning Company’s Caladrix technology to deposit a thin, functional polymer coating without the need for sutures, the vascular stents can be manufactured with improved production rates and yields whilst maintaining efficacy.

What Are Latest Mergers And Acquisitions In The Vascular Stent Market?

In January 2024, Olympus Corporation, a Japan-based company that develops, manufactures, and sells medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. For a $0.370 billion. With this acquisition, Olympus Corporation aims to enhance its gastrointestinal product portfolio, improve patient outcomes, and expand its global market presence in the GI medical device sector. Taewoong Medical Co.Ltd. is a South Korea-based manufacturing company, produces vascular stents to treat narrowed blood vessels and improve circulation.

Regional Outlook

North America was the largest region in the vascular stent market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Stent Market?

The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.